USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Transforming cancer treatment with Immunotherapy (TechVision)
Transforming cancer treatment with Immunotherapy (TechVision)
Fight cancer with Immunotherapy
29-Sep-2015
Global
$4,950.00
Special Price $3,712.50 save 25 %
Description
Cancer immunotherapy is currently part of a transformative wave that has hit the cancer treatment industry. The progress in this space has been rather substantial on both the technical and commercial front. There have been some high profile FDA approvals for drug candidates, that have shown themselves to be very effective, both as monotherapies and adjunct therapies.
Cancer immunotherapy is essentially garnering one’s own immune system and enabling it with the correct tools to attack and destroy the invasive tumors from within. This form of therapy will result in lesser side effects and would be more beneficial than the conventional treatment options that are there.
The development of these checkpoint inhibitor treatments, cellular immune therapies, as well as cancer vaccines, is playing a crucial role in the pharmaceutical industry.
Table of Contents
Scope
Key Findings
Cancer Immunotherapy (CI)
Cancer Immunotherapy (contd…)
Cancer Immunotherapy (contd…)
Cancer Immunotherapy (contd…)
Cancer Immunotherapy (contd…)
Technology Snapshot & Trends
Technology Snapshot & Trends (contd…)
Technology Snapshot & Trends (contd…)
Technology Snapshot & Trends (contd…)
Immune Checkpoint Modulation
Immune Checkpoint Modulation (contd…)
Immune Checkpoint Modulation (contd…)
Immune Checkpoint Modulation (contd…)
Immune Checkpoint Modulation (contd…)
Immune Checkpoint Modulation (contd…)
Cellular Immune Therapy
Cellular Immune Therapy (contd…)
Cellular Immune Therapy (contd…)
Cellular Immune Therapy (contd…)
Cellular Immune Therapy (contd…)
Cancer Treatment Vaccines
Cancer Vaccines (contd…)
Cancer Vaccines (contd…)
Cancer Vaccines (contd…)
Immune modifying agents
Immune modifying agents
Drivers and Restraints
Drivers and Restraints (contd…)
Drivers and Restraints Impact Assessment
Drivers and Restraints Impact Assessment (contd…)
Venture capital investment, Global, 2010-2014
Venture capital investment, Global, 2010-2014 (contd…)
Diffusion of Innovation
Diffusion of Innovation (contd…)
Diffusion of Innovation (contd…)
Diffusion of Innovation (contd…)
Partnerships and Collaborations
Partnerships and Collaborations (contd…)
Company Profiles – Juno Therapeutics
Company Profiles – Kite Pharma
Company Profiles – Bellicum Pharmaceutical
Company Profiles – Advaxis
Company Profiles – Adaptimmune
Patent Landscape
Patent Landscape (contd…)
Key Contacts
Key Contacts (continued)
Key Contacts (continued)
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
| No Index | No |
|---|---|
| Podcast | No |
| Author | Madhumitha Rangesa |
| WIP Number | D6A3-01-00-00-00 |
| Is Prebook | No |